Stryker Corporation (SYK)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for SYK is $365.08, 23.9% above the last close of $294.66 on Oct 16, 2026; targets range from $292.85 to $461.05. Rating consensus: Buy.
Snapshot
- P/E30.5x
- P/E vs sector+8.5%
- P/E vs own-24.2%
- Target upside+23.9%
- ConsensusBuy
- Market cap$113B
- FCF yield+4.2%
- Insiders-$118M
- Earnings in13d
- News0.00
Why it moved
Stryker Corporation (SYK) rose 0.5% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to SYK.
0 stories on the day (30-day average 1.1).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $294.66 · -19.3% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▼ 100▼ 200▼
- Above MAs1 of 4 above
- MA20×50↑ in ~17d
- RSI59
- Support-3.8%
- Resistance+5.3%
- Off 52w high-23.3%
- Off ATH-26.0%
- 52w range$294.66
- Bollingerabove upper
- MACD3.55
- ATR+2.7%
- Volume1.3x
Analyst price targets
21 firms with a target in the last 12 months · last close $294.66 · as of Oct 16, 2026
Strong buy 8 · Buy 15 · Hold 6 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +9.4% year over year, free cash flow 16.1% of revenue, operating margin 25.2%.
| Q2 FY2026 | Jun 30, 2026 | $6.59B | 3.30 | $1.06B | 68.3% | 25.2% | 19.4% |
| Q1 FY2026 | Mar 31, 2026 | $6.02B | 1.93 | $415M | 63.3% | 15.5% | 12.4% |
| Q4 FY2025 | Dec 31, 2025 | $7.17B | 2.20 | $1.88B | 65.2% | 27.3% | 11.8% |
| Q3 FY2025 | Sep 30, 2025 | $6.06B | 2.22 | $1.35B | 63.6% | 18.7% | 14.2% |
| Q2 FY2025 | Jun 30, 2025 | $6.02B | 2.29 | $928M | 65.0% | 18.5% | 14.7% |
| Q1 FY2025 | Mar 31, 2025 | $5.87B | 1.69 | $127M | 62.7% | 20.1% | 11.1% |
| Q4 FY2024 | Dec 31, 2024 | $6.44B | 1.41 | $1.67B | 62.0% | 25.8% | 8.5% |
| Q3 FY2024 | Sep 30, 2024 | $5.49B | 2.16 | $1.3B | 61.8% | 22.0% | 15.2% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $104.89 | +0.2% | -17.7% | +16.6% | 33.7 | $181B | |
| 2 |  | $94.75 | -0.7% | -7.1% | +4.0% | 23.3 | $121B | |
| 3 | | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 4 |  | $44.39 | +0.6% | -57.7% | +50.1% | 18.0 | $64.33B | |
| 5 |  | $86.60 | -1.7% | -9.0% | +15.2% | 49.8 | $49.9B | |
| 6 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 7 |  | $69.57 | -1.1% | -21.0% | +20.2% | 20.2 | $31.42B | |
| 8 |  | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.